CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 122 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $418,309 | +44.5% | 12,376 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $289,475 | -18.8% | 12,376 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $356,429 | +42.2% | 12,376 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $250,738 | -32.6% | 12,376 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $371,899 | +37.6% | 12,376 | +43.9% | 0.00% | 0.0% |
| Q1 2020 | $270,298 | -19.6% | 8,600 | +20.5% | 0.00% | 0.0% |
| Q4 2019 | $336,177 | – | 7,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |